Profil
Michael Snyder is the founder of Personalis, Inc. founded in 2011, SensOmics, Inc. founded in 2015, Mirvie, Inc. founded in 2018, and RTHM, Inc. founded in 2018.
Dr. Snyder is also the founder of Protos LLC,Qbion AB,Filtricine, Inc.,Crosshair Therapeutics, Inc.,January, Inc...
Dr. Snyder is Chair & Genetics Department at Stanford University School of Medicine since 2009.
Dr. Snyder is an Advisor at R42 Group LLC.
Dr. Snyder is an Advisor at Autism Impact Fund.
Dr. Snyder was Director, Center for Genomics & Proteomics at Yale University from 2002 to 2009.
Dr. Snyder completed undergraduate studies at Rochester Christian University.
Dr. Snyder earned a doctorate from California Institute of Technology.
Postes actifs de Michael Snyder
| Sociétés | Poste | Début |
|---|---|---|
R42 GROUP LLC
R42 GROUP LLC Investment ManagersFinance R42 Ventures invests in companies located in the United States. The firm focuses on technological sectors such as AI, biotech and technology. It participates in early stage capital requirements and acts as a lead investor. The firm also makes follow-on and co-investments. | Consultant / Advisor | - |
Qbion AB
Qbion AB Packaged SoftwareTechnology Services Develops and markets radiology simulation software | Fondateur | - |
Protos LLC
Protos LLC Investment ManagersFinance Protos is an active manager which invests in companies located in United States, Asia and Europe. The firm targets companies operating in the fields of information technology, life sciences and wireless applications. It provides financing for seed and early stage capital requirements. | Fondateur | - |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/01/2009 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences and tech-data enable services. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
RTHM, Inc.
RTHM, Inc. Packaged SoftwareTechnology Services Develops AI intelligence platform that provides guidance and care for people with long COVID, ME, CFS, MCAS and POTS related issues | Fondateur | 01/01/2018 |
Anciens postes connus de Michael Snyder
| Sociétés | Poste | Fin |
|---|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/01/2009 |
Filtricine, Inc.
Filtricine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotech company that provides non-drug solutions to cancer | Fondateur | - |
Mirvie, Inc.
Mirvie, Inc. Medical/Nursing ServicesHealth Services Operates as a RNA platform that creates precise, actionable and non-invasive tests for maternal-fetal health | Fondateur | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Michael Snyder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Personalis, Inc.
Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies | Health Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protos LLC
Protos LLC Investment ManagersFinance Protos is an active manager which invests in companies located in United States, Asia and Europe. The firm targets companies operating in the fields of information technology, life sciences and wireless applications. It provides financing for seed and early stage capital requirements. | Finance |
Qbion AB
Qbion AB Packaged SoftwareTechnology Services Develops and markets radiology simulation software | Technology Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SensOmics, Inc.
SensOmics, Inc. Packaged SoftwareTechnology Services Develops genomics, clinical informatics and machine learning to improve understanding of the human genome | Technology Services |
January, Inc.
January, Inc. Financial ConglomeratesFinance Operates as an investment company | Finance |
Filtricine, Inc.
Filtricine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotech company that provides non-drug solutions to cancer | Health Technology |
Mirvie, Inc.
Mirvie, Inc. Medical/Nursing ServicesHealth Services Operates as a RNA platform that creates precise, actionable and non-invasive tests for maternal-fetal health | Health Services |
R42 GROUP LLC
R42 GROUP LLC Investment ManagersFinance R42 Ventures invests in companies located in the United States. The firm focuses on technological sectors such as AI, biotech and technology. It participates in early stage capital requirements and acts as a lead investor. The firm also makes follow-on and co-investments. | Finance |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences and tech-data enable services. It provides financing for early stage capital requirements. | Finance |
RTHM, Inc.
RTHM, Inc. Packaged SoftwareTechnology Services Develops AI intelligence platform that provides guidance and care for people with long COVID, ME, CFS, MCAS and POTS related issues | Technology Services |
















